rs200842904

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_182914.3(SYNE2):​c.7162G>A​(p.Glu2388Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00496 in 1,614,160 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0044 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0050 ( 30 hom. )

Consequence

SYNE2
NM_182914.3 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.0320
Variant links:
Genes affected
SYNE2 (HGNC:17084): (spectrin repeat containing nuclear envelope protein 2) The protein encoded by this gene is a nuclear outer membrane protein that binds cytoplasmic F-actin. This binding tethers the nucleus to the cytoskeleton and aids in the maintenance of the structural integrity of the nucleus. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002536893).
BP6
Variant 14-64031298-G-A is Benign according to our data. Variant chr14-64031298-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 197536.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-64031298-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00442 (673/152342) while in subpopulation NFE AF= 0.00691 (470/68034). AF 95% confidence interval is 0.00639. There are 1 homozygotes in gnomad4. There are 327 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 673 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SYNE2NM_182914.3 linkc.7162G>A p.Glu2388Lys missense_variant Exon 45 of 116 ENST00000555002.6 NP_878918.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SYNE2ENST00000555002.6 linkc.7162G>A p.Glu2388Lys missense_variant Exon 45 of 116 1 NM_182914.3 ENSP00000450831.2 Q8WXH0-2A0A0C4DGK3

Frequencies

GnomAD3 genomes
AF:
0.00442
AC:
673
AN:
152224
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000796
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00216
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.0111
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00691
Gnomad OTH
AF:
0.00143
GnomAD3 exomes
AF:
0.00399
AC:
993
AN:
248798
Hom.:
6
AF XY:
0.00398
AC XY:
537
AN XY:
135088
show subpopulations
Gnomad AFR exome
AF:
0.000714
Gnomad AMR exome
AF:
0.00223
Gnomad ASJ exome
AF:
0.00259
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000294
Gnomad FIN exome
AF:
0.0101
Gnomad NFE exome
AF:
0.00553
Gnomad OTH exome
AF:
0.00480
GnomAD4 exome
AF:
0.00501
AC:
7328
AN:
1461818
Hom.:
30
Cov.:
64
AF XY:
0.00498
AC XY:
3618
AN XY:
727206
show subpopulations
Gnomad4 AFR exome
AF:
0.000717
Gnomad4 AMR exome
AF:
0.00224
Gnomad4 ASJ exome
AF:
0.00233
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000325
Gnomad4 FIN exome
AF:
0.00916
Gnomad4 NFE exome
AF:
0.00574
Gnomad4 OTH exome
AF:
0.00387
GnomAD4 genome
AF:
0.00442
AC:
673
AN:
152342
Hom.:
1
Cov.:
33
AF XY:
0.00439
AC XY:
327
AN XY:
74488
show subpopulations
Gnomad4 AFR
AF:
0.000794
Gnomad4 AMR
AF:
0.00216
Gnomad4 ASJ
AF:
0.00288
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.000415
Gnomad4 FIN
AF:
0.0111
Gnomad4 NFE
AF:
0.00691
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.00523
Hom.:
3
Bravo
AF:
0.00319
TwinsUK
AF:
0.00458
AC:
17
ALSPAC
AF:
0.00571
AC:
22
ESP6500AA
AF:
0.00155
AC:
6
ESP6500EA
AF:
0.00618
AC:
51
ExAC
AF:
0.00406
AC:
491
EpiCase
AF:
0.00562
EpiControl
AF:
0.00551

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Apr 25, 2024
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 01, 2015
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:2
Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

SYNE2: BP4, BS2 -

Feb 03, 2019
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

See Variant Classification Assertion Criteria. -

Emery-Dreifuss muscular dystrophy 5, autosomal dominant Benign:2
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
15
DANN
Benign
0.96
DEOGEN2
Benign
0.017
.;T;T;T
Eigen
Benign
-0.85
Eigen_PC
Benign
-0.73
FATHMM_MKL
Benign
0.069
N
LIST_S2
Benign
0.80
T;T;T;T
MetaRNN
Benign
0.0025
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.5
L;.;L;.
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.76
N;.;N;N
REVEL
Benign
0.071
Sift
Benign
0.19
T;.;T;T
Sift4G
Benign
0.85
T;T;T;T
Polyphen
0.0040
B;.;B;.
Vest4
0.069
MVP
0.24
MPC
0.054
ClinPred
0.0026
T
GERP RS
4.2
Varity_R
0.044
gMVP
0.18

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200842904; hg19: chr14-64498016; API